Eggener SE - Search Results

1

National Prostate Cancer Screening Rates After the 2012 US Preventive Services Task Force Recommendation Discouraging Prostate-Specific Antigen-Based Screening.

Drazer MW, Huo D, Eggener SE. Drazer MW, et al. Among authors: eggener se. J Clin Oncol. 2015 Aug 1;33(22):2416-23. doi: 10.1200/JCO.2015.61.6532. Epub 2015 Jun 8. J Clin Oncol. 2015. PMID: 26056181

2

Predictors of subsequent prostate cancer in men with a prostate specific antigen of 2.6 to 4.0 ng/ml and an initially negative biopsy.

Eggener SE, Roehl KA, Catalona WJ. Eggener SE, et al. J Urol. 2005 Aug;174(2):500-4. doi: 10.1097/01.ju.0000165203.40973.0f. J Urol. 2005. PMID: 16006880

3

Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.

Nadler RB, Loeb S, Roehl KA, Antenor JA, Eggener S, Catalona WJ. Nadler RB, et al. J Urol. 2005 Dec;174(6):2154-7, discussion 2157. doi: 10.1097/01.ju.0000181213.07447.8f. J Urol. 2005. PMID: 16280754

4

A multi-institutional evaluation of active surveillance for low risk prostate cancer.

Eggener SE, Mueller A, Berglund RK, Ayyathurai R, Soloway C, Soloway MS, Abouassaly R, Klein EA, Jones SJ, Zappavigna C, Goldenberg L, Scardino PT, Eastham JA, Guillonneau B. Eggener SE, et al. J Urol. 2009 Apr;181(4):1635-41; discussion 1641. doi: 10.1016/j.juro.2008.11.109. Epub 2009 Feb 23. J Urol. 2009. PMID: 19233410 Free PMC article.

5

Focal therapy for prostate cancer: possibilities and limitations.

Eggener S, Salomon G, Scardino PT, De la Rosette J, Polascik TJ, Brewster S. Eggener S, et al. Eur Urol. 2010 Jul;58(1):57-64. doi: 10.1016/j.eururo.2010.03.034. Epub 2010 Mar 26. Eur Urol. 2010. PMID: 20378241 Review.

6

Population-based patterns and predictors of prostate-specific antigen screening among older men in the United States.

Drazer MW, Huo D, Schonberg MA, Razmaria A, Eggener SE. Drazer MW, et al. Among authors: eggener se. J Clin Oncol. 2011 May 1;29(13):1736-43. doi: 10.1200/JCO.2010.31.9004. Epub 2011 Mar 28. J Clin Oncol. 2011. PMID: 21444863 Free PMC article.

7

Global trends in testicular cancer incidence and mortality.

Rosen A, Jayram G, Drazer M, Eggener SE. Rosen A, et al. Among authors: eggener se. Eur Urol. 2011 Aug;60(2):374-9. doi: 10.1016/j.eururo.2011.05.004. Epub 2011 May 17. Eur Urol. 2011. PMID: 21612857

8

Hazard of prostate cancer specific mortality after radical prostatectomy.

Shikanov S, Eggener SE. Shikanov S, et al. Among authors: eggener se. J Urol. 2012 Jan;187(1):124-7. doi: 10.1016/j.juro.2011.09.044. Epub 2011 Nov 23. J Urol. 2012. PMID: 22114813

9

2008 US Preventive Services Task Force recommendations and prostate cancer screening rates.

Prasad SM, Drazer MW, Huo D, Hu JC, Eggener SE. Prasad SM, et al. Among authors: eggener se. JAMA. 2012 Apr 25;307(16):1692-4. doi: 10.1001/jama.2012.534. JAMA. 2012. PMID: 22535850 No abstract available.

10

Empiric antibiotics for an elevated prostate-specific antigen (PSA) level: a randomised, prospective, controlled multi-institutional trial.

Eggener SE, Large MC, Gerber GS, Pettus J, Yossepowitch O, Smith ND, Kundu S, Kunnavakkam R, Zorn K, Raman JD. Eggener SE, et al. BJU Int. 2013 Nov;112(7):925-9. doi: 10.1111/bju.12241. Epub 2013 Jul 26. BJU Int. 2013. PMID: 23890317 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

336 results

Search Page

Filters